G. Djomand, T. Roels, T. Ellerbrock, D. Hanson, F. Diomande et al., Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d'Ivoire, AIDS, pp.17-22, 2003.

C. Seyler, X. Anglaret, N. Dakoury-dogbo, E. Messou, S. Toure et al., Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Antivir Ther, vol.8, pp.385-393, 2003.

C. Laurent, N. Gueye, N. Ndour, C. Gueye, P. Diouf et al., Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.1, pp.14-17, 2005.
DOI : 10.1097/00126334-200501010-00003

C. Boileau, V. Nguyen, M. Sylla, N. Machouf, A. Chamberland et al., Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.4, pp.476-484, 2008.
DOI : 10.1097/QAI.0b013e31817dc416

R. Granich, C. Gilks, C. Dye, D. Cock, K. Williams et al., Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, The Lancet, vol.373, issue.9657, pp.37348-57, 2009.
DOI : 10.1016/S0140-6736(08)61697-9

A. Ouedraogo, N. Nagot, L. Vergne, I. Konate, H. Weiss et al., Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial, AIDS, vol.20, issue.18, pp.2305-2313, 2006.
DOI : 10.1097/QAD.0b013e328010238d

D. Wilson, M. Law, A. Grulich, D. Cooper, and J. Kaldor, Relation between HIV viral load and infectiousness: a model-based analysis, The Lancet, vol.372, issue.9635, pp.314-320, 2008.
DOI : 10.1016/S0140-6736(08)61115-0

K. Modjarrad, E. Chamot, and S. Vermund, Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression, AIDS, vol.22, issue.16, pp.2179-2185, 2008.
DOI : 10.1097/QAD.0b013e328312c756

U. Fideli, S. Allen, R. Musonda, S. Trask, B. Hahn et al., Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa, AIDS Research and Human Retroviruses, vol.17, issue.10, pp.901-910, 2001.
DOI : 10.1089/088922201750290023

T. Quinn, M. Wawer, N. Sewankambo, D. Serwadda, C. Li et al., Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1, New England Journal of Medicine, vol.342, issue.13, pp.921-929, 2000.
DOI : 10.1056/NEJM200003303421303

D. Cock, K. Gilks, C. Lo, Y. Guerma, and T. , Can antiretroviral therapy eliminate HIV transmission? Lancet, pp.7-9, 2009.

N. Nagot, A. Ouangre, A. Ouedraogo, M. Cartoux, P. Huygens et al., Spectrum of Commercial Sex Activity in Burkina Faso: Classification Model and Risk of Exposure to HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.5, pp.517-521, 2002.
DOI : 10.1097/00042560-200204150-00013

M. Alary and C. Lowndes, The central role of clients of female sex workers in the dynamics of heterosexual HIV transmission in sub-Saharan Africa, AIDS, vol.18, issue.6, pp.945-947, 2004.
DOI : 10.1097/00002030-200404090-00013

L. Morison, H. Weiss, A. Buve, M. Carael, S. Abega et al., Commercial sex and the spread of HIV in four cities in sub-Saharan Africa, AIDS, vol.15, pp.15-61, 2001.
DOI : 10.1097/00002030-200108004-00007

A. Cote, F. Sobela, A. Dzokoto, K. Nzambi, C. Asamoah-adu et al., Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana, AIDS, vol.18, issue.6, pp.917-925, 2004.
DOI : 10.1097/00002030-200404090-00009

M. Alary, L. Mukenge-tshibaka, F. Bernier, N. Geraldo, C. Lowndes et al., Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, AIDS, vol.16, pp.1993-1999463, 2002.

P. Ghys, M. Diallo, V. Ettiegne-traore, K. Kale, O. Tawil et al., Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, AIDS, vol.16, pp.1991-1998251, 2002.

N. Nagot, A. Ouedraogo, A. Ouangre, M. Cartoux, M. Defer et al., Is Sexually Transmitted Infection Management Among Sex Workers Still Able to Mitigate the Spread of HIV Infection in West Africa?, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.39, issue.4, pp.454-458, 2005.
DOI : 10.1097/01.qai.0000152399.54648.b9

. Huet, http://www.biomedcentral.com/1471-2458/11/700 levels with therapy to suppress herpes simplex virus, BMC Public Health N Engl J Med, vol.11, issue.356, pp.700790-799, 2007.

N. Meda, L. Gautier-charpentier, R. Soudre, H. Dahourou, R. Ouedraogo-traore et al., Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits. Bull World Health Organ, pp.731-739, 1999.

F. Rouet, M. Chaix, E. Nerrienet, N. Ngo-giang-huong, J. Plantier et al., Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.4, pp.380-388, 2007.
DOI : 10.1097/QAI.0b013e3180640cf5

E. Van-dyck, A. Buve, H. Weiss, J. Glynn, D. Brown et al., Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations, Journal of Clinical Microbiology, vol.42, issue.7, pp.422961-2965, 2004.
DOI : 10.1128/JCM.42.7.2961-2965.2004

M. Brinkhof, F. Dabis, L. Myer, D. Bangsberg, A. Boulle et al., Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries, Bull World Health Organ, vol.86, pp.559-567, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00182959

J. Etard, I. Ndiaye, M. Thierry-mieg, N. Gueye, P. Gueye et al., Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1189, 2006.
DOI : 10.1097/01.aids.0000226959.87471.01

S. Toure, B. Kouadio, C. Seyler, M. Traore, N. Dakoury-dogbo et al., Rapid scaling-up of antiretroviral therapy in 10 000 adults in C??te d??Ivoire: 2-year outcomes and determinants, AIDS, vol.22, issue.7, pp.873-882, 2008.
DOI : 10.1097/QAD.0b013e3282f768f8

A. Boulle, P. Bock, M. Osler, K. Cohen, L. Channing et al., Antiretroviral therapy and early mortality in South Africa, Bulletin of the World Health Organization, vol.86, issue.9, pp.678-687, 2008.
DOI : 10.2471/BLT.07.045294

P. Braitstein, M. Brinkhof, F. Dabis, M. Schechter, A. Boulle et al., Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and highincome countries, Lancet, issue.9513, pp.367817-824, 2006.

S. Lawn, A. Harries, X. Anglaret, L. Myer, and R. Wood, Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa, AIDS, vol.22, issue.15, pp.1897-1908, 2008.
DOI : 10.1097/QAD.0b013e32830007cd
URL : https://hal.archives-ouvertes.fr/inserm-00266588

M. Marazzi, G. Liotta, P. Germano, G. Guidotti, A. Altan et al., Excessive Early Mortality in the First Year of Treatment in HIV Type 1-Infected Patients Initiating Antiretroviral Therapy in Resource-Limited Settings, AIDS Research and Human Retroviruses, vol.24, issue.4, pp.555-560, 2008.
DOI : 10.1089/aid.2007.0217

O. Keiser, C. Orrell, M. Egger, R. Wood, M. Brinkhof et al., Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared, PLoS Medicine, vol.368, issue.7, p.148, 2008.
DOI : 10.1371/journal.pmed.0050148.sd001

M. Egger, M. May, G. Chene, A. Phillips, B. Ledergerber et al., Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, The Lancet, vol.360, issue.9327, pp.119-129, 2002.
DOI : 10.1016/S0140-6736(02)09411-4

D. Coetzee, K. Hildebrand, A. Boulle, G. Maartens, F. Louis et al., Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa, AIDS, vol.18, issue.6, pp.887-895, 2004.
DOI : 10.1097/00002030-200404090-00006

C. Celum, R. Levine, M. Weaver, and W. A. , Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ, pp.447-453, 2004.

O. Manigart, V. Courgnaud, O. Sanou, D. Valea, N. Nagot et al., HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure, AIDS, vol.18, issue.12, pp.1645-1651, 2004.
DOI : 10.1097/01.aids.0000131333.30548.db

C. Hoffmann, K. Fielding, S. Charalambous, M. Sulkowski, C. Innes et al., Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events, AIDS, vol.22, issue.1, pp.67-74, 2008.
DOI : 10.1097/QAD.0b013e3282f2306e

R. Hamers, I. Derdelinckx, M. Van-vugt, W. Stevens, R. De-wit et al., The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa, Antivir Ther, vol.13, pp.625-639, 2008.

D. Tebit, L. Sangare, A. Makamtse, S. Yameogo, H. Somlare et al., HIV Drug Resistance Pattern Among HAART-Exposed Patients With Suboptimal Virological Response in Ouagadougou, Burkina Faso, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.1, pp.17-25, 2008.
DOI : 10.1097/QAI.0b013e318182d2bc

S. Goldie, Y. Yazdanpanah, E. Losina, M. Weinstein, X. Anglaret et al., Cost-Effectiveness of HIV Treatment in Resource-Poor Settings ??? The Case of C??te d'Ivoire, New England Journal of Medicine, vol.355, issue.11, pp.3551141-1153, 2006.
DOI : 10.1056/NEJMsa060247